Table 5.

Summary of all adverse events

Part A	Regimen A (n = 20)	Regimen B (n = 19)
Preferred Term	n (%)	n (%)
Upper respiratory tract infection	0	2 (11)
Headache	1 (5)	1 (5)

Part B	Regimen C (n = 20)	Regimen D (n = 19)
Preferred Term	n (%)	n (%)
Diarrhea	2 (10)	1 (5)
Constipation	1 (5)	1 (5)
Nausea	0	2 (11)
Aphthous stomatitis	0	1 (5)
Tongue coated	0	1 (5)
Vomiting	1 (5)	0
Vulvovaginal mycotic infection	0	2 (11)
Rhinitis	0	1 (5)
Catheter site phlebitis	0	1 (5)

Descriptions of regimens: A = 15 mg pioglitazone + 10 mg rosuvastatin; B = 15 mg pioglitazone + 10 mg rosuvastatin + 100 mg daprodustat; C = 25 mg daprodustat; D = 25 mg daprodustat + 200 mg trimethoprim BID for 5 days.